Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17.3M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
+14.9M
-
Total reported value, excl. options
-
$151M
-
Value change
-
+$150M
-
Number of buys
-
41
-
Price
-
$10.02
Significant Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q4 2024
42 filings reported holding TDACU - Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 as of Q4 2024.
Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 17.3M outstanding shares and own 87.05% of the company stock.
Largest 10 shareholders include AQR Arbitrage LLC (1.49M shares), Magnetar Financial LLC (1.3M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (900K shares), LMR Partners LLP (800K shares), Polar Asset Management Partners Inc. (800K shares), K2 PRINCIPAL FUND, L.P. (675K shares), First Trust Capital Management L.P. (650K shares), Hudson Bay Capital Management LP (650K shares), TENOR CAPITAL MANAGEMENT Co., L.P. (635K shares), and Crossingbridge Advisors, LLC (600K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.